Browsing by Author "Fonseca, I"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
- Doença de Addison em associação com tuberculose pulmonar: a propósito de uma caso clínicoPublication . Silva, R; Marques, M; Fonseca, I; Ferrão, J; Saldanha, MH
- Doença de Kikuchi-Fujimoto: uma causa pouco frequente de adenopatias cervicaisPublication . Pina, R; Fonseca, I; Saldanha, MH
- Ependimoma intramedular: Revisão da literatura – A propósito de um caso clínicoPublication . Batista, R; Pina, R; Fonseca, I; Saldanha, MH
- Neurofibromatose tipo 1 e feocromocitoma: a propósito de um caso clínicoPublication . Norte, A; Alves, P; Batista, M; Barbosa, B; Fonseca, I; Saldanha, MH
- Prognostic Value of Isolated Elevated Troponin I Levels in Patients without Acute Coronary Syndrome Admitted to the Emergency DepartmentPublication . Domingues, C; Ferreira, MJ; Ferreira, JM; Marinho, AV; Alves, PM; Ferreira, C; Fonseca, I; Gonçalves, LBackground: Although non-ischemic troponin elevation is frequently seen in patients admitted to the emergency department (ED), consensus regarding its management is lacking. Objectives: This study aimed to characterize patients admitted to the ED with non-ischemic troponin elevation and to identify potential mortality predictors in this population. Methods: This retrospective observational study included ED patients with a positive troponin test result between June and July of 2015. Patients with a clinical diagnosis of acute coronary syndrome (ACS) were excluded. Data on patient demographics and clinical and laboratory variables were extracted from medical records. Follow-up data were obtained for 16 months or until death occurred. The statistical significance level was 5%. Results: Troponin elevation without ACS was found in 153 ED patients. The median (IQR) patient age was 78 (19) years, 80 (52.3%) were female and 59(38.6%) died during follow-up. The median (IQR) follow-up period was 477(316) days. Survivors were significantly younger 76 (24) vs. 84 (13) years; p=0.004) and featured a higher proportion of isolated troponin elevation (without creatine kinase or myoglobin elevation) in two consecutive evaluations: 48 (53.9%) vs. 8 (17.4%), p<0.001. Survivors also presented a lower rate of antiplatelet treatment and same-day hospitalization. In the multivariate logistic regression with adjustment for significant variables in the univariate analysis, isolated troponin elevation in two consecutive evaluations showed a hazard ratio= 0.43 (95%CI 0.17-0.96, p=0.039); hospitalization, previous antiplatelet treatment and age remained independently associated with mortality. Conclusions: Isolated troponin elevation in two consecutive measurements was a strong predictor of survival in ED patients with troponin elevation but without ACS.
- Tromboembolia pulmonar de risco elevado com trombos na cavidade auricular direitaPublication . Saraiva, F; Fonseca, I; Martins, R; Gonçalves, L; Providência, LA